Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma

Overview of attention for article published in Clinical Cancer Research, May 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 14 news outlets

twitter: 5 tweeters

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 6 Mendeley

Summary News Twitter Dimensions citations

So far, Altmetric has seen 5 tweets from 5 users, with an upper bound of 24,947 followers.

https://t.co/R3jhr2tcKW Nice work by Andrew Brenner's group. My two cents on the mechanism of how a fatty acid synthase inhibitor would synergize with Avastin.

24 Jun 2023

Reply Retweet Favourite

Researchers conduct clinical trial of a specific drug combination for lethal brain #cancer glioblastoma https://t.co/O1gYkDoXoo https://t.co/pPFhGXiE7n

23 May 2023

Reply Retweet Favourite

RT @EANOassociation: Phase II Investigation of TVB-2640 (denifanstat) with Bevacizumab in Patients with First Relapse High-Grade #Astrocyto…

25 Apr 2023

Reply Retweet Favourite

RT @EANOassociation: Phase II Investigation of TVB-2640 (denifanstat) with Bevacizumab in Patients with First Relapse High-Grade #Astrocyto…

25 Apr 2023

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 1 additional tweets.